OpenArc Corporate Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
OpenArc Corporate Advisory's NVS Position: Q2 2026 in Review
OpenArc Corporate Advisory increased its Novartis (NVS) stake by 3.5% in Q2 2026, buying an estimated $67.5K and bringing the position to 13,228 shares worth $2.07M. The position accounts for 0.02% of the portfolio, ranked #257.
OpenArc Corporate Advisory first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- OpenArc Corporate Advisory held 13,228 shares of Novartis worth $2.07M as of Q2 2026.
- OpenArc Corporate Advisory bought 450 Novartis shares in Q2 2026, an estimated $67.5K.
- Novartis made up 0.02% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #257 holding.
- OpenArc Corporate Advisory first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.